Concepedia

Alfonso Zambon

AZ

Statistics

Publications

42

Citations

3.3K

H-Index

26

Active since

2000

Affiliations

Institute of Cancer Research(Current)

Cancer Research UK

Ca' Foscari University of Venice

University of Modena and Reggio Emilia

University of Manchester

Alfonso Zambon is an author at Institute of Cancer Research specializing in medicinal chemistry, pharmacy, and oncology.

ORCID

Publications per year

2000–2023

42

Publications

42

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

, , +13

Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden et al. · Cancer Discovery · 2012 · 373 citations · Full text

, , +17

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma

María Romina Girotti, Filipa M. Lopes, Natasha Preece et al. · Cancer Cell · 2014 · 209 citations · Full text

, , +17

Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies

Steven R. Whittaker, Robert Hayward, Alfonso Zambon et al. · Science Translational Medicine · 2010 · 155 citations · Full text

, , +17

s-Heptazine oligomers: promising structural models for graphitic carbon nitride

Alfonso Zambon, Jean‐Marie Mouesca, Cristina C. Gheorghiu et al. · Chemical Science · 2015 · 139 citations · Full text

, , +4

1–5 of 42